Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Boehringer Ingelheim
US Department of Justice
Accenture
McKesson
Cipla
Citi
Chinese Patent Office
Deloitte

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,821,236

« Back to Dashboard

Summary for Patent: 5,821,236
Title: Tumor treatment with arabinofuranosyl purine derivatives
Abstract:6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.
Inventor(s): Krenitsky; Thomas Anthony (Chapel Hill, NC), Averett; Devron Randolph (Raleigh, NC), Koszalka; George Walter (Chapel Hill, NC)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:08/449,078
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,821,236

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,821,236

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9015914Jul 19, 1990

International Patents Family Members for US Patent 5,821,236

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 151637 ➤ Subscribe
Australia 641533 ➤ Subscribe
Australia 8196091 ➤ Subscribe
Canada 2087543 ➤ Subscribe
Cyprus 2165 ➤ Subscribe
Germany 69125715 ➤ Subscribe
Denmark 0539479 ➤ Subscribe
European Patent Office 0539479 ➤ Subscribe
Spain 2103311 ➤ Subscribe
United Kingdom 9015914 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Baxter
Dow
Deloitte
Express Scripts
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot